Unmet Needs With Recurrent C Difficile Infections

The panelist discusses how recurrent Clostridioides difficile infections represent a critical health care challenge, characterized by unmet needs in long-term prevention, microbiome restoration, and personalized treatment. The field is evolving toward precision medicine approaches, leveraging advanced diagnostics, innovative therapeutic modalities such as engineered probiotics and bacteriophage therapies, and comprehensive strategies that integrate microbial, immunological, and genetic insights to improve patient outcomes.

EP: 1.The Role of Testing for C Difficile in Clinical Practice

EP: 2.Utilizing Antibiotics in Treatment of C Difficile

EP: 3.Examining FMT for Patients With Recurrent C Difficile infections

EP: 4.Exploring Rebyota for Recurrent C Difficile Infections

EP: 5.Key Data Supporting the Use of Rebyota in Patients With Recurrent C Difficile Infections

EP: 6.Vowst as a Potential Option for Patients With Recurrent C Difficile Infections

EP: 7.Management of Recurrent C Difficile Infections in the Future

EP: 8.Key Background Information on Recurrent C. Difficile Infections

EP: 9.Importance of Early Detection of Recurrent C Difficile Infections

EP: 10.Impact of Recurrent C Difficile Infection on Costs and Patient Quality of Life

EP: 11.Diagnosis of Recurrent C Difficile Infections

EP: 12.Common Comorbidities Associated With Recurrent C Difficile Infections

Now Viewing

EP: 13.Unmet Needs With Recurrent C Difficile Infections

Video content above is prompted by the following:

What are the main unmet needs for recurrent C difficile infections and how do you see the field evolving in the future?

Related Videos

Related Content

Advertisement

January 19th 2025

AI Outperforms Traditional Methods in Predicting Ovarian Cancer Surgery Outcomes

Brooke McCormick

Artificial intelligence (AI) models, particularly artificial neural networks and machine learning, outperform traditional methods in predicting post–complete cytoreduction outcomes in patients with ovarian cancer, including overall survival, no residual disease, and postoperative complications.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

January 17th 2025

Understanding gMG: Autoantibodies and Life-Altering Muscle Weakness

Maggie L. Shaw

Generalized myasthenia gravis (gMG) is an autoantibody-driven chronic disease for which there is no cure.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

January 17th 2025

Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney Disease

Zachary Villaverde, BS Roy H. Hinman II, MD Richard M. Grimes, PhD

Patients with diabetes and chronic kidney disease receiving physiologic insulin resensitization had much lower annual costs of care than similar patients not receiving it.

January 16th 2025

Kent Hospital MPN Initiative Focuses on Supportive Care

Mary Caffrey

Besides Kent Hospital, the Association of Cancer Care Centers worked with Perlmutter Cancer Center at NYU Langone Hospital and Charleston Area Medical Center Vandalia Health in Charleston, West Virginia.

Related Content

Advertisement

January 19th 2025

AI Outperforms Traditional Methods in Predicting Ovarian Cancer Surgery Outcomes

Brooke McCormick

Artificial intelligence (AI) models, particularly artificial neural networks and machine learning, outperform traditional methods in predicting post–complete cytoreduction outcomes in patients with ovarian cancer, including overall survival, no residual disease, and postoperative complications.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

January 17th 2025

Understanding gMG: Autoantibodies and Life-Altering Muscle Weakness

Maggie L. Shaw

Generalized myasthenia gravis (gMG) is an autoantibody-driven chronic disease for which there is no cure.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

January 17th 2025

Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney Disease

Zachary Villaverde, BS Roy H. Hinman II, MD Richard M. Grimes, PhD

Patients with diabetes and chronic kidney disease receiving physiologic insulin resensitization had much lower annual costs of care than similar patients not receiving it.

January 16th 2025

Kent Hospital MPN Initiative Focuses on Supportive Care

Mary Caffrey

Besides Kent Hospital, the Association of Cancer Care Centers worked with Perlmutter Cancer Center at NYU Langone Hospital and Charleston Area Medical Center Vandalia Health in Charleston, West Virginia.